These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38284690)

  • 21. Percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disorders.
    Santucci NR; Sahay R; El-Chammas KI; Graham K; Wheatley M; Vandenbrink M; Hardy J; Fei L
    Front Pain Res (Lausanne); 2023; 4():1251932. PubMed ID: 37795388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing Costs and Outcomes of Treatments for Irritable Bowel Syndrome With Diarrhea: Cost-Benefit Analysis.
    Shah ED; Salwen-Deremer JK; Gibson PR; Muir JG; Eswaran S; Chey WD
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):136-144.e31. PubMed ID: 33010413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous electrical nerve field stimulation modulates central pain pathways and attenuates post-inflammatory visceral and somatic hyperalgesia in rats.
    Babygirija R; Sood M; Kannampalli P; Sengupta JN; Miranda A
    Neuroscience; 2017 Jul; 356():11-21. PubMed ID: 28526575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: the economic impact of the irritable bowel syndrome.
    Canavan C; West J; Card T
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1023-34. PubMed ID: 25199904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome.
    Patel A; Hasak S; Cassell B; Ciorba MA; Vivio EE; Kumar M; Gyawali CP; Sayuk GS
    Aliment Pharmacol Ther; 2016 Aug; 44(3):246-58. PubMed ID: 27240555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Magnetic Resonance Imaging Evaluation of Auricular Percutaneous Electrical Neural Field Stimulation for Fibromyalgia: Protocol for a Feasibility Study.
    Gebre M; Woodbury A; Napadow V; Krishnamurthy V; Krishnamurthy LC; Sniecinski R; Crosson B
    JMIR Res Protoc; 2018 Feb; 7(2):e39. PubMed ID: 29410385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland.
    Fisher M; Walker A; Falqués M; Moya M; Rance M; Taylor D; Lindner L
    Eur J Health Econ; 2016 Dec; 17(9):1091-1100. PubMed ID: 26728984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High risk of temporomandibular disorder in irritable bowel syndrome: Is there a correlation with greater illness severity?
    Gallotta S; Bruno V; Catapano S; Mobilio N; Ciacci C; Iovino P
    World J Gastroenterol; 2017 Jan; 23(1):103-109. PubMed ID: 28104985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain.
    Nyrop KA; Palsson OS; Levy RL; Von Korff M; Feld AD; Turner MJ; Whitehead WE
    Aliment Pharmacol Ther; 2007 Jul; 26(2):237-48. PubMed ID: 17593069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agreement between prospective diary data and retrospective questionnaire report of abdominal pain and stooling symptoms in children with irritable bowel syndrome.
    Self MM; Williams AE; Czyzewski DI; Weidler EM; Shulman RJ
    Neurogastroenterol Motil; 2015 Aug; 27(8):1110-9. PubMed ID: 26017930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.
    Mearin F; Caballero AM; Serra J; Brotons C; Tantiñà A; Fort E; Martínez-Cerezo FJ; Perelló A; Sánchez-Antolín G; Rey E; Angós Musgo R; Berdier R; Gómez-Rodríguez B; Clavé P; García-Alonso M; Torán-Monserrat P; Tack J
    Gastroenterol Hepatol; 2019 Mar; 42(3):141-149. PubMed ID: 30612850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of internet-delivered cognitive-behavioural therapy for adolescents with irritable bowel syndrome.
    Sampaio F; Bonnert M; Olén O; Hedman E; Lalouni M; Lenhard F; Ljótsson B; Ssegonja R; Serlachius E; Feldman I
    BMJ Open; 2019 Jan; 9(1):e023881. PubMed ID: 30679293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptom Profiles in Patients With Irritable Bowel Syndrome or Functional Abdominal Pain Compared With Healthy Controls.
    Varni JW; Shulman RJ; Self MM; Nurko S; Saps M; Saeed SA; Bendo CB; Patel AS; Dark CV; Zacur GM; Pohl JF;
    J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):323-9. PubMed ID: 26020482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of eye movement desensitization and reprocessing (EMDR) on abdominal pain in patients with irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (EMDR4IBS).
    Wertheim B; Aarts EE; de Roos C; van Rood YR
    Trials; 2023 Dec; 24(1):785. PubMed ID: 38049872
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Martoni CJ; Srivastava S; Leyer GJ
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of osteopathic manipulative therapy for managing symptoms of irritable bowel syndrome: a systematic review.
    Müller A; Franke H; Resch KL; Fryer G
    J Am Osteopath Assoc; 2014 Jun; 114(6):470-9. PubMed ID: 24917634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iyengar yoga for adolescents and young adults with irritable bowel syndrome.
    Evans S; Lung KC; Seidman LC; Sternlieb B; Zeltzer LK; Tsao JC
    J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):244-53. PubMed ID: 25025601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of electroacupuncture at homotopic and heterotopic acupoints on abdominal pain in patients with irritable bowel syndrome: study protocol for a randomized controlled trial.
    Peng Y; You H; Chen X; Chen Y; Yang Y; Huang J; Xu N; Liu J
    Trials; 2018 Oct; 19(1):559. PubMed ID: 30326940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homeopathy for treatment of irritable bowel syndrome.
    Peckham EJ; Cooper K; Roberts ER; Agrawal A; Brabyn S; Tew G
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009710. PubMed ID: 31483486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.